Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type

It is important to clarify the histologic progression of intrahepatic cholangiocarcinoma (ICC) in consideration of its origin from the intrahepatic large or small biliary ducts. On the basis of the gross and histologic assessment, we classified 87 cases of ICC smaller than 5 cm in diameter into hilar type (H-ICC, n=38) or peripheral type (P-ICC, n=49) to compare their clinical and histologic features. Biliary dysplasia was observed in 65.8% (25/38) of H-ICC cases, whereas hepatitis virus infection and liver cirrhosis were associated with 46.7% (21/45) and 28.6% (14/49) of P-ICC, respectively. The frequency of perineural invasion, lymph node metastasis, and extrahepatic recurrence of H-ICC was significantly higher than that of P-ICC (P<0.0001, 0.0106, and 0.0279, respectively). H-ICC cases showed frequent vascular invasion and intrahepatic metastasis even with small tumor size, compared with P-ICC cases. H-ICC showed large duct involvement within the tumor, and in the cases of large tumor size, intraductal spread was detected in the tumor periphery. P-ICC of small size contained preserved architecture of the portal tracts. The survival of patients with H-ICC was worse than that of patients with P-ICC (P=0.0121). The independent and best prognostic factor by multivariate analysis was intrahepatic metastasis for H-ICC and lymph node metastasis for P-ICC. Our results suggest that ICCs derived from a different level of biliary ducts were related to different premalignant conditions and different tumor progression. Some ICCs arising from the large biliary duct are likely to exhibit an aggressive course even in cases of small tumor size. The recognition of the above events induces the proper therapy.

[1]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[2]  P. Watanapa,et al.  Liver fluke‐associated cholangiocarcinoma , 2002, The British journal of surgery.

[3]  P. Johnson,et al.  Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma , 1991, Cancer.

[4]  T. Roskams,et al.  Preneoplastic lesions in human hepatocarcinogenesis , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[5]  T. Roskams.  Liver stem cells and their implication in hepatocellular and cholangiocarcinoma , 2006, Oncogene.

[6]  Y. Maehara,et al.  Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology , 2004, Modern Pathology.

[7]  R. DePinho,et al.  Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. , 2006, Cancer research.

[8]  K. Takasaki,et al.  Minute nodular intrahepatic cholangiocarcinoma , 1998, Cancer.

[9]  J. Fujimoto,et al.  Clinicopathologic spectrum of resected extraductal mass‐forming intrahepatic cholangiocarcinoma , 1995, Cancer.

[10]  J. Figueras,et al.  Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma , 2004, Annals of surgery.

[11]  S. Fan,et al.  Intrahepatic Cholangiocarcinoma , 1997, World Journal of Surgery.

[12]  H. Hussain,et al.  Magnetic resonance imaging of cholangiocarcinoma , 2004, Cancer imaging : the official publication of the International Cancer Imaging Society.

[13]  Y. Atomi,et al.  Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: Preliminary report based on interobserver agreement , 2005, Pathology international.

[14]  K. Chayama,et al.  Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis , 2000, Cancer.

[15]  K. Sugimachi,et al.  Coexpression of neural cell adhesion molecules and bcl‐2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: Relationship to atypical reactive bile ductule , 2002, Pathology international.

[16]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[17]  F. Callea,et al.  Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy , 2001, Cancer Causes & Control.

[18]  M. Ito,et al.  Relationship of intrahepatic bile duct hyperplasia to cholangiocellular carcinoma , 1988, Cancer.

[19]  B. I. Choi,et al.  Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings. , 1993, AJR. American journal of roentgenology.

[20]  Motoko Sasaki,et al.  Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. , 2003, Journal of hepato-biliary-pancreatic surgery.

[21]  M. Kojiro,et al.  Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy‐proven cases , 1977, Cancer.

[22]  G. Gores,et al.  Primary Sclerosing Cholangitis and Cholangiocarcinoma , 2006, Seminars in liver disease.

[23]  M. Kudo.  Early Detection and Characterization of Hepatocellular Carcinoma: Value of Imaging Multistep Human Hepatocarcinogenesis , 2005, Intervirology.

[24]  M. F. Chen,et al.  Peripheral cholangiocarcinoma (cholangiocellular carcinoma): Clinical features, diagnosis and treatment , 1999, Journal of gastroenterology and hepatology.

[25]  Y. Nakanuma,et al.  Precancerous lesions of intrahepatic cholangiocarcinoma. , 2000, Journal of hepato-biliary-pancreatic surgery.

[26]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[27]  Erik Schrumpf,et al.  Diagnosis and treatment of cholangiocarcinoma , 2004, Current gastroenterology reports.

[28]  Sun-Whe Kim,et al.  Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma , 2000, Hepatology.

[29]  Masakazu Yamamoto,et al.  Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular‐cholangiocarcinoma) in Japan , 1993, Cancer.

[30]  Philip M. Long,et al.  Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling , 2005, Hepatology.

[31]  Yoshiyuki Suzuki,et al.  Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis , 2006, Cancer.

[32]  Wen-lLiang Wang,et al.  Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. , 1998, World journal of gastroenterology.

[33]  Y. Maehara,et al.  Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour , 2006, Histopathology.

[34]  G. Klatskin.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. , 1965, The American journal of medicine.

[35]  M. Dayton,et al.  Caroli's Disease: a premalignant condition? , 1983, American journal of surgery.

[36]  Tohru Takahashi,et al.  The development and extension of hepatohilar bile duct carcinoma. A three‐dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system , 1989, Cancer.

[37]  Randall G. Lee,et al.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. , 1998, Annals of surgery.

[38]  T Nakajima,et al.  A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. , 1988, Human pathology.